1. Home
  2. ZLAB vs UAA Comparison

ZLAB vs UAA Comparison

Compare ZLAB & UAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • UAA
  • Stock Information
  • Founded
  • ZLAB 2013
  • UAA 1996
  • Country
  • ZLAB China
  • UAA United States
  • Employees
  • ZLAB N/A
  • UAA N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • UAA Apparel
  • Sector
  • ZLAB Health Care
  • UAA Consumer Discretionary
  • Exchange
  • ZLAB Nasdaq
  • UAA Nasdaq
  • Market Cap
  • ZLAB 3.0B
  • UAA 3.5B
  • IPO Year
  • ZLAB 2017
  • UAA N/A
  • Fundamental
  • Price
  • ZLAB $26.67
  • UAA $10.08
  • Analyst Decision
  • ZLAB Strong Buy
  • UAA Hold
  • Analyst Count
  • ZLAB 4
  • UAA 19
  • Target Price
  • ZLAB $52.50
  • UAA $9.34
  • AVG Volume (30 Days)
  • ZLAB 1.1M
  • UAA 12.0M
  • Earning Date
  • ZLAB 11-12-2024
  • UAA 11-07-2024
  • Dividend Yield
  • ZLAB N/A
  • UAA N/A
  • EPS Growth
  • ZLAB N/A
  • UAA N/A
  • EPS
  • ZLAB N/A
  • UAA N/A
  • Revenue
  • ZLAB $355,748,000.00
  • UAA $5,400,928,000.00
  • Revenue This Year
  • ZLAB $48.50
  • UAA N/A
  • Revenue Next Year
  • ZLAB $47.37
  • UAA $1.76
  • P/E Ratio
  • ZLAB N/A
  • UAA N/A
  • Revenue Growth
  • ZLAB 35.01
  • UAA N/A
  • 52 Week Low
  • ZLAB $13.48
  • UAA $6.17
  • 52 Week High
  • ZLAB $36.60
  • UAA $11.89
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 41.98
  • UAA 58.65
  • Support Level
  • ZLAB $27.74
  • UAA $9.38
  • Resistance Level
  • ZLAB $32.15
  • UAA $11.89
  • Average True Range (ATR)
  • ZLAB 1.36
  • UAA 0.49
  • MACD
  • ZLAB -0.64
  • UAA 0.08
  • Stochastic Oscillator
  • ZLAB 3.15
  • UAA 39.24

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

About UAA Under Armour Inc.

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.

Share on Social Networks: